{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:01:04Z","timestamp":1791018064376,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6464,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1111\/j.1538-7836.2005.01227.x","type":"journal-article","created":{"date-parts":[[2005,4,4]],"date-time":"2005-04-04T10:46:39Z","timestamp":1112611599000},"page":"742-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count"],"prefix":"10.1016","volume":"3","author":[{"given":"T.","family":"LISMAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"ADELMEIJER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"CAUWENBERGHS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.M.","family":"VAN PAMPUS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.W.M.","family":"HEEMSKERK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.G.","family":"DE GROOT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1055\/s-0037-1615876","article-title":"Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa","volume":"82","author":"Hedner","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00007890-200102150-00011","article-title":"Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study","volume":"71","author":"Hendriks","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/gast.2002.34164","article-title":"Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy","volume":"123","author":"Jeffers","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0037-1963(01)90143-X","article-title":"Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia","volume":"38","author":"Poon","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0030","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-0037-1615209","article-title":"Treatment of a patient with Bernard\u2013Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa","volume":"80","author":"Peters","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ajh.1060","article-title":"Successful treatment with recombinant factor VIIa of therapy\u2010resistant severe bleeding in a patient with acquired von Willebrand disease","volume":"66","author":"Friederich","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0040","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00001721-199811000-00003","article-title":"The effect of recombinant factor VIIa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0","volume":"9","author":"Erhardtsen","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0045","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/01.CIR.0000038501.87442.02","article-title":"Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers","volume":"106","author":"Bijsterveld","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(03)12268-4","article-title":"Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double\u2010blind placebo\u2010controlled randomised trial","volume":"361","author":"Friederich","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0055","first-page":"431","article-title":"Recombinant activated factor VII for adjunctive hemorrhage control in trauma","volume":"51","author":"Martinowitz","year":"2001","journal-title":"J Trauma"},{"issue":"Suppl. 2","key":"10.1111\/j.1538-7836.2005.01227.x_bb0060","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1007\/s00134-002-1472-6","article-title":"Ongoing NovoSeven (R) trials","volume":"28","author":"Erhardtsen","year":"2002","journal-title":"Intensive Care Med"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2005.01227.x_bb0065","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/00001721-200306001-00010","article-title":"Update on Novo Nordisk's clinical trial programme on NovoSeven","volume":"14","author":"Dejgaard","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2005.01227.x_bb0070","first-page":"159","article-title":"Clinical experience with recombinant factor VIIa in patients with thrombocytopenia","volume":"26","author":"Kristensen","year":"1996","journal-title":"Haemostasis"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajh.10056","article-title":"Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life\u2010threatening hemorrhage","volume":"69","author":"Gerotziafas","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0049-3848(03)00146-4","article-title":"Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits","volume":"109","author":"Tranholm","year":"2003","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0085","first-page":"5","article-title":"Mechanism of action of recombinant activated factor VII","volume":"5","author":"Lisman","year":"2003","journal-title":"TATM"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0090","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1172\/JCI116691","article-title":"The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor","volume":"92","author":"Ten Cate","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V99.1.175","article-title":"Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe haemophilia A","volume":"99","author":"Lisman","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0100","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.V95.4.1330.004k28_1330_1335","article-title":"Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa","volume":"95","author":"Van\u2018t Veer","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood.V83.1.38.38","article-title":"Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high\u2010dose factor VIIa in hemophilia","volume":"83","author":"Hoffman","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high\u2010dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0115","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2002-09-2761","article-title":"Recombinant factor VIIa enhances deposition of platelets with congenital or acquired {alpha}IIb{beta}3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor\u2010independent thrombin generation","volume":"101","author":"Lisman","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0120","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1046\/j.1538-7836.2003.00225.x","article-title":"Mechanism of action of recombinant factor VIIa","volume":"1","author":"Lisman","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0125","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.V99.3.923","article-title":"Mechanism of factor VIIa\u2010dependent coagulation in hemophilia blood","volume":"99","author":"Butenas","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0130","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1046\/j.1538-7836.2003.00242.x","article-title":"The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII\/FIX","volume":"1","author":"He","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2000-8455","article-title":"The factor VII\u2013platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia","volume":"26","author":"Monroe","year":"2000","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0140","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1365-2141.2001.02870.x","article-title":"High\u2010dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia\u2010like conditions in a cell\u2010based model system","volume":"114","author":"Kjalke","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0037-1963(01)90142-8","article-title":"Effect of recombinant factor VIIa (Novoseven) on thrombocytopenia\u2010like conditions in vitro","volume":"38","author":"Kjalke","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0150","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1537-2995.2003.00427.x","article-title":"Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders","volume":"43","author":"Galan","year":"2003","journal-title":"Transfusion"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0155","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2003-07-2287","article-title":"Recombinant factor VIIa restores aggregation of {alpha}IIb{beta}3\u2010deficient platelets via tissue factor\u2010independent fibrin generation","volume":"103","author":"Lisman","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0160","doi-asserted-by":"crossref","first-page":"30160","DOI":"10.1074\/jbc.272.48.30160","article-title":"Tissue factor positions and maintains the factor VIIa active site far above the membrane surface even in the absence of the factor VIIa Gla domain. A fluorescence resonance energy transfer study","volume":"272","author":"McCallum","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0165","doi-asserted-by":"crossref","first-page":"21051","DOI":"10.1016\/S0021-9258(17)31928-2","article-title":"Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa","volume":"269","author":"Hackeng","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0170","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI113721","article-title":"Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor","volume":"82","author":"Koedam","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0175","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(98)00159-5","article-title":"A new perfusion chamber to detect platelet adhesion using a small volume of blood","volume":"92","author":"Sixma","year":"1998","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0180","first-page":"522","article-title":"A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel walls, their extracellular matrix, and purified components","volume":"102","author":"Sakariassen","year":"1983","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0185","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/01.ATV.20.6.1661","article-title":"Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor\u2013glycoprotein Ib interaction and inhibited by von Willebrand factor\u2013glycoprotein IIb\/IIIa interaction","volume":"20","author":"Wu","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0190","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2003-03-0889","article-title":"Platelet receptor interplay regulates collagen\u2010induced thrombus formation in flowing human blood","volume":"103","author":"Siljander","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0195","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1469-7793.2001.00625.x","article-title":"Ragged spiking of free calcium in ADP\u2010stimulated human platelets: regulation of puff\u2010like calcium signals in vitro and ex vivo","volume":"535","author":"Heemskerk","year":"2001","journal-title":"J Physiol"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2005.01227.x_bb0200","first-page":"S61","article-title":"Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high\u2010dose activated factor VII","volume":"9","author":"Hoffman","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0205","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease\u2010activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0210","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1073\/pnas.98.4.1823","article-title":"A thrombin receptor function for platelet glycoprotein Ib\u2010IX unmasked by cleavage of glycoprotein V","volume":"98","author":"Ramakrishnan","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0215","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.96.23.13336","article-title":"Increased thrombin responsiveness in platelets from mice lacking glycoprotein V","volume":"96","author":"Ramakrishnan","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0220","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.V98.2.368","article-title":"Increased thrombogenesis and embolus formation in mice lacking glycoprotein V","volume":"98","author":"Ni","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0225","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1046\/j.1432-1033.2003.03670.x","article-title":"Glycoprotein Ib\u2010mediated platelet activation. A signalling pathway triggered by thrombin","volume":"270","author":"Adam","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.1087734","article-title":"Structural biology. A menage a trois in two configurations","volume":"301","author":"Sadler","year":"2003","journal-title":"Science"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0235","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1126\/science.1083917","article-title":"Crystal structure of the GpIbalpha\u2013thrombin complex essential for platelet aggregation","volume":"301","author":"Dumas","year":"2003","journal-title":"Science"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0240","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.1084183","article-title":"Modulation of alpha\u2010thrombin function by distinct interactions with platelet glycoprotein Ibalpha","volume":"301","author":"Celikel","year":"2003","journal-title":"Science"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0037-1963(01)90141-6","article-title":"Recombinant factor VIIa (Novoseven) restores deficient coagulation: experience from an ex vivo model","volume":"38","author":"Galan","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2005.01227.x_bb0250","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0168-8278(03)00454-9","article-title":"Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model","volume":"39","author":"Tonda","year":"2003","journal-title":"J Hepatol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2005.01227.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622158526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622158526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2005.01227.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:33:05Z","timestamp":1761532385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622158526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S1538783622158526"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01227.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01227.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}